Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 8146, October 1, 2008. doi: 10.1158/0008-5472.CAN-08-0945
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gagos, S.
Right arrow Articles by Antonarakis, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gagos, S.
Right arrow Articles by Antonarakis, S. E.

Molecular Biology, Pathobiology, and Genetics

Pericentromeric Instability and Spontaneous Emergence of Human Neoacrocentric and Minute Chromosomes in the Alternative Pathway of Telomere Lengthening

Sarantis Gagos1, Maria Chiourea1, Agni Christodoulidou1, Eftichia Apostolou2, Christina Raftopoulou1, Samuel Deustch3, Charles-Edward Jefford4, Irmgard Irminger-Finger4, Jerry W. Shay5 and Stylianos E. Antonarakis3

1 Laboratory of Genetics and 2 Laboratory of Molecular Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; 3 Department of Genetic Medicine and Development, University of Geneva Medical School; 4 Laboratory of Molecular Gynecology and Obstetrics, Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland; and 5 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas

Requests for reprints: Sarantis Gagos, Soranou Efessiou 4, Athens 11527, Greece. Phone: 30-210-659-7471; Fax: 30-210-659-7545; E-mail: sgagos{at}bioacademy.gr.

Key Words: alternative lengthening of telomeres (ALT) • chromosomal instability in neoplasia (CIN) • pericentromeric instability • telomerase inhibition

In the alternative pathway of telomere lengthening (ALT), neoplastic cell growth is prolonged by telomere recombination. We show that ALT is unexpectedly characterized by high rates of ongoing pericentromeric chromosomal instability. Combined with telomeric recombination, ALT pericentromeric instability generates neoacrocentric chromosomes. In the present studies, we describe a subgroup of ALT neoacrocentric minute chromosomes, composed of DNA entities two to five times smaller in size than human chromosome 21. The frequencies of ALT minute chromosomes were increased by {gamma}-irradiation and suppressed by telomerase. Continuous growth after telomerase inhibition/depletion was followed by increased rates of telomeric sister chromatid recombination and the emergence of minute chromosomes. We show that ALT minute chromosomes were derived from true centromeric fissions and/or chromosomal breakage/fusion/bridge cycles. They exhibit a two-chromatid structure, carry genomic DNA, centromeric and telomeric repeats, and display regular mitotic functionality. These observations are important in understanding the global genomic instability that characterizes most human advanced malignancies. [Cancer Res 2008;68(19):8146–55]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.